Inhibrx Biosciences, Inc. INBX
77.66 USD -5.64 (-6.77%)
Regular-session close
77.66 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
76.50 Day range 84.71
57.30 52-week range 155.29
- YTD
- -1.70%
- 1 year
- -1.86%
News
benzinga.com Inhibrx Biosciences Analyst Cuts Price Target Despite Data Catalysts In 2027 HC Wainwright keeps Buy on INBX, cuts PT after wider loss; cash supports 2027 catalysts, though equity raise is expected.benzinga.com HC Wainwright & Co. Maintains Buy on Inhibrx Biosciences, Lowers Price Target to $220 HC Wainwright & Co. analyst Robert Burns maintains Inhibrx Biosciences (NASDAQ:INBX) with a Buy and lowers the price target from $245 to $220.
prnewswire.com Inhibrx Reports Third Quarter 2026 Financial Results SAN DIEGO, Nov. 13, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) (Inhibrx or the Company) today reported financial results for the third quarter of 2026. The biopharmaceutical…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Pulmonx (NASDAQ:LUNG) stock increased by 33.1% to $2.63 during Wednesday's regular session. The company's market cap stands at $85.0 million. As per the press release, Q3 earnings came out…
